These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24057292)

  • 1. An activating mutation in the kinase homology domain of the natriuretic peptide receptor-2 causes extremely tall stature without skeletal deformities.
    Hannema SE; van Duyvenvoorde HA; Premsler T; Yang RB; Mueller TD; Gassner B; Oberwinkler H; Roelfsema F; Santen GW; Prickett T; Kant SG; Verkerk AJ; Uitterlinden AG; Espiner E; Ruivenkamp CA; Oostdijk W; Pereira AM; Losekoot M; Kuhn M; Wit JM
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1988-98. PubMed ID: 24057292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Activating Deletion Variant in the Submembrane Region of Natriuretic Peptide Receptor-B Causes Tall Stature.
    Lauffer P; Miranda-Laferte E; van Duyvenvoorde HA; van Haeringen A; Werner F; Boudin E; Schmidt H; Mueller TD; Kuhn M; van der Kaay DCM
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2354-66. PubMed ID: 32282051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development.
    Hachiya R; Ohashi Y; Kamei Y; Suganami T; Mochizuki H; Mitsui N; Saitoh M; Sakuragi M; Nishimura G; Ohashi H; Hasegawa T; Ogawa Y
    J Clin Endocrinol Metab; 2007 Oct; 92(10):4009-14. PubMed ID: 17652215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
    Dickey DM; Otto NM; Potter LR
    J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overgrowth syndrome associated with a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene.
    Miura K; Kim OH; Lee HR; Namba N; Michigami T; Yoo WJ; Choi IH; Ozono K; Cho TJ
    Am J Med Genet A; 2014 Jan; 164A(1):156-63. PubMed ID: 24259409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and in silico analyses validates pathogenicity of homozygous mutations in the NPR2 gene underlying variable phenotypes of Acromesomelic dysplasia, type Maroteaux.
    Irfanullah ; Zeb A; Shinwari N; Shah K; Gilani SZT; Khan S; Lee KW; Raza SI; Hussain S; Liaqat K; Ahmad W
    Int J Biochem Cell Biol; 2018 Sep; 102():76-86. PubMed ID: 30016695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature.
    Olney RC; Bükülmez H; Bartels CF; Prickett TC; Espiner EA; Potter LR; Warman ML
    J Clin Endocrinol Metab; 2006 Apr; 91(4):1229-32. PubMed ID: 16384845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature.
    Vasques GA; Amano N; Docko AJ; Funari MF; Quedas EP; Nishi MY; Arnhold IJ; Hasegawa T; Jorge AA
    J Clin Endocrinol Metab; 2013 Oct; 98(10):E1636-44. PubMed ID: 24001744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acromesomelic dysplasia, type maroteaux caused by novel loss-of-function mutations of the NPR2 gene: Three case reports.
    Wang W; Song MH; Miura K; Fujiwara M; Nawa N; Ohata Y; Kitaoka T; Kubota T; Namba N; Jin DK; Kim OH; Ozono K; Cho TJ
    Am J Med Genet A; 2016 Feb; 170A(2):426-434. PubMed ID: 26567084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.
    Robinson JW; Dickey DM; Miura K; Michigami T; Ozono K; Potter LR
    Bone; 2013 Oct; 56(2):375-82. PubMed ID: 23827346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse.
    Tsuji T; Kunieda T
    J Biol Chem; 2005 Apr; 280(14):14288-92. PubMed ID: 15722353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons.
    Schmidt H; Dickey DM; Dumoulin A; Octave M; Robinson JW; Kühn R; Feil R; Potter LR; Rathjen FG
    J Neurosci; 2018 Nov; 38(45):9768-9780. PubMed ID: 30249793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.
    Miura K; Namba N; Fujiwara M; Ohata Y; Ishida H; Kitaoka T; Kubota T; Hirai H; Higuchi C; Tsumaki N; Yoshikawa H; Sakai N; Michigami T; Ozono K
    PLoS One; 2012; 7(8):e42180. PubMed ID: 22870295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells.
    Rahmutula D; Gardner DG
    Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous sequence variants in the NPR2 gene underlying Acromesomelic dysplasia Maroteaux type (AMDM) in consanguineous families.
    Irfanullah ; Umair M; Khan S; Ahmad W
    Ann Hum Genet; 2015 Jul; 79(4):238-44. PubMed ID: 25959430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.
    Edmund AB; Walseth TF; Levinson NM; Potter LR
    Sci Signal; 2019 Jan; 12(566):. PubMed ID: 30696704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Natriuretic Peptide Receptor 2 Promotes Bicuspid Aortic Valves, Aortic Valve Disease, Left Ventricular Dysfunction, and Ascending Aortic Dilatations in Mice.
    Blaser MC; Wei K; Adams RLE; Zhou YQ; Caruso LL; Mirzaei Z; Lam AY; Tam RKK; Zhang H; Heximer SP; Henkelman RM; Simmons CA
    Circ Res; 2018 Feb; 122(3):405-416. PubMed ID: 29273600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of NPR2 mutation in idiopathic short stature: Identification of two novel mutations.
    Hwang IT; Mizuno Y; Amano N; Lee HJ; Shim YS; Nam HK; Rhie YJ; Yang S; Lee KH; Hasegawa T; Kang MJ
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1146. PubMed ID: 31960617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short Stature is Progressive in Patients with Heterozygous NPR2 Mutations.
    Hanley PC; Kanwar HS; Martineau C; Levine MA
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3190-202. PubMed ID: 32720985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathogenic NPR2 variants in short stature patients and the therapeutic response to rhGH.
    Chen H; Zhang S; Sun Y; Chen J; Yuan K; Zhang Y; Yang X; Lin X; Chen R
    Orphanet J Rare Dis; 2023 Jul; 18(1):221. PubMed ID: 37501190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.